COGNITIVE DEFICITS AND FUNCTIONAL OUTCOMES IN MAJOR DEPRESSIVE DISORDER: DETERMINANTS, SUBSTRATES, AND TREATMENT INTERVENTIONS

被引:669
作者
McIntyre, Roger S. [1 ,2 ,3 ,4 ]
Cha, Danielle S. [3 ,4 ]
Soczynska, Joanna K. [3 ,4 ]
Woldeyohannes, Hanna O. [2 ]
Gallaugher, Laura Ashley [2 ]
Kudlow, Paul [2 ]
Alsuwaidan, Mohammad [3 ]
Baskaran, Anusha [2 ,5 ]
机构
[1] Univ Toronto, Inst Med Sci, Toronto, ON M5T 2S8, Canada
[2] Univ Hlth Network, Mood Disorders Psychopharmacol Unit, Toronto, ON, Canada
[3] Univ Toronto, Dept Psychiat, Toronto, ON M5T 2S8, Canada
[4] Univ Toronto, Dept Pharmacol, Toronto, ON M5T 2S8, Canada
[5] Queens Univ, Ctr Neurosci Studies, Kingston, ON, Canada
关键词
major depressive disorder; cognitive dysfunction; cognitive deficits; dementia; duloxetine; vortioxetine; functional outcome; EARLY-LIFE STRESS; BIPOLAR DISORDER; LU AA21004; NEUROCOGNITIVE DEFICITS; ELDERLY-PATIENTS; MOOD DISORDERS; DOUBLE-BLIND; EXECUTIVE DYSFUNCTION; MULTIMODAL COMPOUND; INSULIN-RESISTANCE;
D O I
10.1002/da.22063
中图分类号
B849 [应用心理学];
学科分类号
040203 [应用心理学];
摘要
Background Few reports have aimed to describe the mediational effect of cognitive deficits on functional outcomes in major depressive disorder (MDD), and relatively few interventions are demonstrated to mitigate cognitive deficits in MDD. Methods Studies enrolling subjects between the ages of 18-65 were selected for review. Bibliographies from identified articles were reviewed to identify additional original reports aligned with our objectives. Results Cognitive deficits in MDD are consistent, replicable, nonspecific, and clinically significant. The aggregated estimated effect size of cognitive deficits in MDD is small to medium. Pronounced deficits in executive function (1 SD below the normative mean) are evident in approximate to 20-30% of individuals with MDD). Other replicated abnormalities are in the domains of working memory, attention, and psychomotor processing speed. Mediational studies indicate that cognitive deficits may account for the largest percentage of variance with respect to the link between psychosocial dysfunction (notably workforce performance) and MDD. No conventional antidepressant has been sufficiently studied and/or demonstrated robust procognitive effects in MDD. Conclusions Cognitive deficits in MDD are a principal mediator of psychosocial impairment, notably workforce performance. The hazards posed by cognitive deficits in MDD underscore the need to identify a consensus-based neurocognitive battery for research and clinical purposes. Interventions (pharmacological, behavioral, neuromodulatory) that engage multiple physiological systems implicated in cognitive deficits hold promise to reduce, reverse, and prevent cognitive deficits. (C) 2013 Wiley Periodicals, Inc.
引用
收藏
页码:515 / 527
页数:13
相关论文
共 96 条
[1]
Is cognitive impairment following early life stress in severe mental disorders based on specific or general cognitive functioning? [J].
Aas, Monica ;
Steen, Nils E. ;
Agartz, Ingrid ;
Aminoff, Sofie R. ;
Lorentzen, Steinar ;
Sundet, Kjetil ;
Andreassen, Ole A. ;
Melle, Ingrid .
PSYCHIATRY RESEARCH, 2012, 198 (03) :495-500
[2]
Low episodic memory performance as a premorbid marker of depression:: evidence from a 3-year follow-up [J].
Airaksinen, E. ;
Wahlin, A. ;
Forsell, Y. ;
Larsson, M. .
ACTA PSYCHIATRICA SCANDINAVICA, 2007, 115 (06) :458-465
[3]
A double-blind, randomized, placebo-controlled, active reference study of Lu AA21004 in patients with major depressive disorder [J].
Alvarez, Enric ;
Perez, Victor ;
Dragheim, Marianne ;
Loft, Henrik ;
Artigas, Francesc .
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2012, 15 (05) :589-600
[4]
Combining redox-proteomics and epigenomics to explain the involvement of oxidative stress in psychiatric disorders [J].
Andreazza, Ana Cristina .
MOLECULAR BIOSYSTEMS, 2012, 8 (10) :2503-2512
[5]
Insulin Resistance and Alzheimer-like Reductions in Regional Cerebral Glucose Metabolism for Cognitively Normal Adults With Prediabetes or Early Type 2 Diabetes [J].
Baker, Laura D. ;
Cross, Donna J. ;
Minoshima, Satoshi ;
Belongia, Dana ;
Watson, Stennis ;
Craft, Suzanne .
ARCHIVES OF NEUROLOGY, 2011, 68 (01) :51-57
[6]
Discovery of 1-[2-(2,4-Dimethylphenylsulfanyl)phenyl]piperazine (Lu AA21004): A Novel Multimodal Compound for the Treatment of Major Depressive Disorder [J].
Bang-Andersen, Benny ;
Ruhland, Thomas ;
Jorgensen, Morten ;
Smith, Garrick ;
Frederiksen, Kristen ;
Jensen, Klaus Gjervig ;
Zhong, Huailing ;
Nielsen, Soren Moller ;
Hogg, Sandra ;
Mork, Arne ;
Stensbol, Tine Bryan .
JOURNAL OF MEDICINAL CHEMISTRY, 2011, 54 (09) :3206-3221
[7]
EMPLOYER BURDEN OF MILD, MODERATE, AND SEVERE MAJOR DEPRESSIVE DISORDER: MENTAL HEALTH SERVICES UTILIZATION AND COSTS, AND WORK PERFORMANCE [J].
Birnbaum, Howard G. ;
Kessler, Ronald C. ;
Kelley, David ;
Ben-Hamadi, Rym ;
Joish, Vijay N. ;
Greenberg, Paul E. .
DEPRESSION AND ANXIETY, 2010, 27 (01) :78-89
[8]
Microglia as modulators of cognition and neuropsychiatric disorders [J].
Blank, Thomas ;
Prinz, Marco .
GLIA, 2013, 61 (01) :62-70
[9]
Cognitive endophenotypes of bipolar disorder: A meta-analysis of neuropsychological deficits in euthymic patients and their first-degree relatives [J].
Bora, Emre ;
Yucel, Murat ;
Pantelis, Christos .
JOURNAL OF AFFECTIVE DISORDERS, 2009, 113 (1-2) :1-20
[10]
Bowie C.R., 2012, American Journal of Psychiatry